Literature DB >> 18519479

Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: potential factors influencing a changing dynamic.

Melanie P McGraw1, Jeffrey M Perlman.   

Abstract

OBJECTIVE: The objective of this study was to determine the attitude of neonatal providers toward delivery room resuscitation of an infant with confirmed trisomy 18 with known congenital heart disease at >/=36 weeks of gestation.
METHODS: A multiple-choice questionnaire listing this clinical scenario was completed by neonatologists and fellows staffing level III NICUs. Potential factors influencing the decision to initiate resuscitation included maternal preference, neonatal condition at birth, obstetric care, and legal concerns.
RESULTS: Fifty-four (76%) of 71 surveys were completed. Of respondents, 44% indicated that they would be willing to initiate resuscitation. Maternal preference (70%) was the primary reason to initiate resuscitation, with the appearance of the neonate in the delivery room (46%) and legal concerns (25%) as additional factors.
CONCLUSIONS: Until recently, there was universal consensus that trisomy 18 was a lethal anomaly for which resuscitation in the delivery room was not indicated. These data indicate that more providers (44%) than anticipated would consider initiation of resuscitation for an infant with trisomy 18 even with congenital heart disease. We speculate that support for the best-interest standard for neonates is diminishing in favor of ceding without question to parental autonomy. This shift may have profound implications for ethical decisions in the NICU.

Entities:  

Mesh:

Year:  2008        PMID: 18519479     DOI: 10.1542/peds.2007-1869

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  The self-fulfilling prophecy in intensive care.

Authors:  Dominic Wilkinson
Journal:  Theor Med Bioeth       Date:  2009

2.  Pediatric sub-specialist controversies in the treatment of congenital heart disease in trisomy 13 or 18.

Authors:  Andrew R Yates; Timothy M Hoffman; Edward Shepherd; Bethany Boettner; Kim L McBride
Journal:  J Genet Couns       Date:  2011-05-18       Impact factor: 2.537

3.  Major anomalies and birth-weight influence NICU interventions and mortality in infants with trisomy 13 or 18.

Authors:  K Acharya; S Leuthner; R Clark; T H Nghiem-Rao; A Spitzer; J Lagatta
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

4.  Trisomy 18 syndrome: Towards a balanced approach.

Authors:  Hassan Batees; Khalid A Altirkawi
Journal:  Sudan J Paediatr       Date:  2014

5.  Parent Perspectives of Support Received from Physicians and/or Genetic Counselors Following a Decision to Continue a Pregnancy with a Prenatal Diagnosis of Trisomy 13/18.

Authors:  Stephanie E Wallace; Sara Gilvary; Michael J Smith; Siobhan M Dolan
Journal:  J Genet Couns       Date:  2017-10-27       Impact factor: 2.537

6.  "You Can Carry the Torch Now:" A Qualitative Analysis of Parents' Experiences Caring for a Child with Trisomy 13 or 18.

Authors:  Joshua D Arthur; Divya Gupta
Journal:  HEC Forum       Date:  2017-09

7.  Major chromosomal anomalies among very low birth weight infants in the Vermont Oxford Network.

Authors:  Nansi S Boghossian; Jeffrey D Horbar; Joseph H Carpenter; Jeffrey C Murray; Edward F Bell
Journal:  J Pediatr       Date:  2011-12-16       Impact factor: 4.406

8.  Cardiac surgery in patients with trisomy 18.

Authors:  Yukihiro Kaneko; Jotaro Kobayashi; Ikuya Achiwa; Hitoshi Yoda; Keiji Tsuchiya; Yayohi Nakajima; Daiichi Endo; Hajime Sato; Tadashi Kawakami
Journal:  Pediatr Cardiol       Date:  2009-04-02       Impact factor: 1.655

9.  Phenotypic extremes in liveborn monozygotic twins with mosaic Edwards syndrome.

Authors:  Neidin Bussmann; Katie Cunningham; Andrew Green; C Anthony Ryan
Journal:  BMJ Case Rep       Date:  2015-11-11

10.  Communication about life-sustaining therapy: insights from the Adaptive Leadership Framework.

Authors:  Elizabeth Neglia; Ruth A Anderson; Debra Brandon; Sharron L Docherty
Journal:  Eur J Pers Cent Healthc       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.